Home » Newsletters » BioWorld

BioWorld

July 2, 1996

View Archived Issues

SIGNS OF ROUGH TIMES AHEAD FOR BIOTECHNOLOGY FINANCING?

VERTEX PHARMACEUTICALS, GLAXO PAY $25M TO AVOID POTENTIAL PROTEASE

ARE BIOTECH'S DAYS OF WINE AND ROSES COMING TO AN END?

ONCE-A-MONTH SHOT, NOT DAILY INJECTIONS ALKERMES TESTING SLOW RELEASE

OTHER NEWS TO NOTE

RESEARCHERS IDENTIFY LONGEST SEGMENT OF DNA; A STEP CLOSER TO

FDA APPROVES IMMUNOMEDICS' COLORECTAL CANCER DIAGNOSTIC